欧州のタンパク質シーケンシング市場：用途別、エンドユーザー別、国別 - 分析と予測（2024年～2033年）

欧州のタンパク質シーケンシングの市場規模は、2024年の4億7,720万米ドルから2033年には6億8,560万米ドルに達し、予測期間の2024年～2033年のCAGRは4.11%になると予測されています。

タンパク質シーケンシングは、タンパク質中のアミノ酸の正確な順序を決定するプロセスであり、タンパク質の構造、機能、生体システムにおける役割を理解するために不可欠です。バイオテクノロジー、生物医学研究、創薬、疾病診断において重要な役割を果たし、精密医療や標的治療の進歩に大きく貢献しています。タンパク質シーケンシングは、翻訳後修飾、タンパク質相互作用、疾患メカニズムに関する貴重な洞察を提供し、ライフサイエンスとヘルスケアにおけるブレークスルーを支援します。

欧州では、プロテオミクス研究への投資の増加、バイオ医薬品産業の拡大、個別化医療への需要の増加を背景に、タンパク質シーケンシングの導入が加速しています。主なシーケンシング技術は、小さなタンパク質に有効なエドマン分解と、高いスループットと複雑なサンプルの解析能力により大規模プロテオミクスに広く利用されている質量分析の2つです。市場は、シーケンシングプロセスを促進する機器、試薬、消耗品と、専門的なシーケンシングサービスを提供する受託研究機関から構成されます。

バイオマーカー探索、医薬品開発、疾病診断に対する需要の高まりが、タンパク質シーケンシング技術の絶え間ない革新を促しています。政府の強力な支援、民間投資の増加、強固な研究エコシステムにより、欧州はプロテオミクスとタンパク質ベースの研究で大きく成長する態勢を整えています。

欧州のタンパク質シーケンシング市場は、プロテオミクス研究への投資の増加、バイオ医薬品産業の拡大、個別化医療への需要の高まりなどを背景に、着実な成長を遂げています。タンパク質中のアミノ酸の正確な順序を決定するタンパク質シーケンシングは、タンパク質の構造、機能、相互作用の理解に不可欠です。創薬、疾病診断、バイオマーカー同定において重要な役割を果たし、精密医療や標的療法の進歩を支えています。

同市場は主に、質量分析やエドマン分解などのシーケンス技術の進歩によって牽引されています。質量分析は、複雑なタンパク質サンプルを効率的に解析できることから、ハイスループットプロテオミクスに広く利用されている一方、エドマン分解は、より小さなタンパク質の配列決定に依然として関連しています。欧州では、政府からの資金援助や研究機関、製薬会社、バイオテクノロジー企業間の共同研究により、技術革新に力を入れており、この分野のさらなる開発が促進されています。

市場成長を後押しする主な要因としては、腫瘍学、神経変性疾患、感染症研究における応用の拡大が挙げられます。さらに、プロテオミクスにおける人工知能や機械学習の採用が増加しており、データ解析能力が強化されています。研究エコシステムが確立され、ライフサイエンスへの投資が拡大している欧州のタンパク質シーケンシング市場は、プロテオミクスとバイオメディカル研究の未来を形成し、長期的な拡大が見込まれています。

当レポートでは、欧州のタンパク質シーケンシング市場について調査し、市場の概要とともに、用途別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 欧州のタンパク質シーケンシング市場：概要

• 動向：現在および将来の影響評価
• タンパク質配列決定のワークフロー
• 規制の枠組み
• 市場力学の概要

第2章 タンパク質シーケンシング市場（地域別）、100万米ドル、2022年～2033年

• 地域サマリー
• 欧州
  • 地域概要
  • 市場成長促進要因
  • 市場成長抑制要因
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他

第3章 市場-競合情勢

• 欧州のタンパク質シーケンシング市場：競合情勢
  • 企業戦略2021年1月～2024年9月
  • パートナーシップ、提携、事業拡大
• 企業プロファイル
  • Merck KGaA
  • Proteome Factory AG
  • Selvita S.A.

第4章 調査手法

List of Figures

• Figure 1: Europe Protein Sequencing Market, $Million, 2024, 2028, and 2033
• Figure 2: Protein Sequencing Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Europe Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
• Figure 4: Europe Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
• Figure 5: Key Events to Keep Track of in the Protein Sequencing Market
• Figure 6: Protein Sequencing Workflow Overview
• Figure 7: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
• Figure 8: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
• Figure 9: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 10: Germany Protein Sequencing Market, $Million, 2022-2033
• Figure 11: U.K. Protein Sequencing Market, $Million, 2022-2033
• Figure 12: France Protein Sequencing Market, $Million, 2022-2033
• Figure 13: Italy Protein Sequencing Market, $Million, 2022-2033
• Figure 14: Spain Protein Sequencing Market, $Million, 2022-2023
• Figure 15: Rest-of-Europe Protein Sequencing Market, $Million, 2022-2033
• Figure 16: Corporate Strategies, January 2021- September 2024
• Figure 17: Data Triangulation
• Figure 18: Top-Down and Bottom-Up Approach
• Figure 19: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Europe Protein Sequencing Market Opportunities
• Table 3: Product Launches, January 2023-September 2024
• Table 4: Companies Providing Single-Molecule Protein Sequencing
• Table 5: List of Molecular Targets Identified with Proteomics
• Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
• Table 7: Europe Protein Sequencing Market (by End User), $Million, 2022-2033
• Table 8: Europe Protein Sequencing Market (by Application), $Million, 2022-2033
• Table 9: Partnerships, Alliances, and Business Expansions (by Company), January 2021-September 2024

Introduction to Europe Protein Sequencing Market

The Europe protein sequencing market is projected to reach $685.6 million by 2033 from $477.2 million in 2024, growing at a CAGR of 4.11% during the forecast period 2024-2033. Protein sequencing is the process of determining the precise order of amino acids in a protein, essential for understanding its structure, function, and role in biological systems. It plays a crucial role in biotechnology, biomedical research, drug discovery, and disease diagnostics, significantly contributing to advancements in precision medicine and targeted therapies. Protein sequencing provides valuable insights into post-translational modifications, protein interactions, and disease mechanisms, supporting breakthroughs in life sciences and healthcare.

In Europe, the adoption of protein sequencing is accelerating, driven by growing investments in proteomics research, the expansion of the biopharmaceutical industry, and increasing demand for personalized medicine. The two primary sequencing techniques are Edman degradation, which is effective for smaller proteins, and mass spectrometry, widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. The market comprises instruments, reagents, and consumables that facilitate sequencing processes, alongside contract research organizations providing specialized sequencing services.

Rising demand for biomarker discovery, drug development, and disease diagnostics is driving continuous innovation in protein sequencing technologies. With strong government support, increasing private-sector investments, and a robust research ecosystem, Europe is poised for significant growth in proteomics and protein-based research.

Market Introduction

The Europe protein sequencing market is experiencing steady growth, driven by increasing investments in proteomics research, expanding biopharmaceutical industries, and the rising demand for personalized medicine. Protein sequencing, which determines the precise order of amino acids in a protein, is essential for understanding protein structures, functions, and interactions. It plays a crucial role in drug discovery, disease diagnostics, and biomarker identification, supporting advancements in precision medicine and targeted therapies.

The market is primarily driven by advancements in sequencing technologies such as mass spectrometry and Edman degradation. Mass spectrometry is widely used for high-throughput proteomics due to its ability to analyze complex protein samples efficiently, while Edman degradation remains relevant for sequencing smaller proteins. Europe's strong focus on innovation, supported by government funding and collaborations between research institutions, pharmaceutical companies, and biotechnology firms, is fostering further developments in this field.

Key factors propelling market growth include increasing applications in oncology, neurodegenerative diseases, and infectious disease research. Additionally, the rising adoption of artificial intelligence and machine learning in proteomics is enhancing data analysis capabilities. With a well-established research ecosystem and growing investments in life sciences, the European protein sequencing market is poised for long-term expansion, shaping the future of proteomics and biomedical research.

Market Segmentation:

Segmentation 1: By Application

• Biotherapeutics
• Genetic Engineering
• Others

Segmentation 2: By End User

• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies

Segmentation 3: By Region

• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Selvita
• Merck KGaA
• Proteome Factory AG

Table of Contents

Executive Summary

Scope and Definition

1 Europe Protein Sequencing Market: Overview

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Product Launches in the Market
  • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
  • 1.1.3 High Demand for Biologics Development
• 1.2 Workflow of Protein Sequencing
  • 1.2.1 Protein Sequencing Workflow Overview
• 1.3 Regulatory Framework
  • 1.3.1 European Union (EU)
    • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.1.1.1 EU Medical Device Regulation
      • 1.3.1.1.2 EU In Vitro Diagnostic Regulation
    • 1.3.1.2 Regulatory Requirements for Clinical Protein Sequencing

Labs in the EU 26

• 1.4 Patent Analysis
  • 1.4.1 Patent Filing Trend (by Country)
  • 1.4.2 Patent Filing Trend (by Year)
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Europe Protein Engineering Market
    • 1.5.1.2 Expanding Applications in Research
    • 1.5.1.3 Technological Advancements in Protein Sequencing
  • 1.5.2 Market Restraints
    • 1.5.2.1 Shortage of Skilled Labour
    • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Protein Sequencing Market (By Region), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Germany
  • 2.2.5 U.K.
  • 2.2.6 France
  • 2.2.7 Italy
  • 2.2.8 Spain
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Landscape

• 3.1 Europe Protein Sequencing Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2021-September 2024
  • 3.1.2 Partnerships, Alliances, and Business Expansions
• 3.2 Company Profiles
  • 3.2.1 Merck KGaA
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Proteome Factory AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Services Offered
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 Selvita S.A.
    • 3.2.3.1 Overview
    • 3.2.3.2 Services Offered
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End Users
    • 3.2.3.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast